Top compounds associated with response to FXYD2


Feature Type Standardized
Nominal ANOVA
mRNA CIL41 CTRPv2 pan-cancer AAC 0.026 0.6
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.018 0.6
mRNA nintedanib CTRPv2 pan-cancer AAC 0.018 0.6
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.6
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.7
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.019 0.7
mRNA PD-0325901 gCSI pan-cancer AAC -0.025 0.7
mRNA tandutinib CTRPv2 pan-cancer AAC 0.018 0.7
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC 0.039 0.7
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.018 0.7
Download CSV